ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In a recently published study regarding SARS-CoV-2 and the liver, Luxenberger et al. suggest that the probable mechanisms contributing to more severe disease in patients with NAFLD involve the impairments of T cell immunity and adipokine imbalance, as well as leptin and adiponectin, which might suppress T cell-mediated immune responses [20].